Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-24 @ 5:08 PM
Study NCT ID:
NCT04120350
Status:
UNKNOWN
Last Update Posted:
2020-06-05
First Post:
2019-09-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty
Sponsor:
Peking Union Medical College Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-28
First Submit QC Date:
None
Study First Post Date:
2019-10-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-03
Last Update Post Date:
2020-06-05
Last Update Post Date Type:
ACTUAL